I
schemic stroke is the third leading cause of death worldwide and a leading cause of adult disability. Ischemic insult causes rapid cell death and a disruption of functional circuits such as the neurovascular unit (NVU) in the affected areas. The most serious clinical complication of cerebral ischemia is brain swelling due to brain edema. 1 The lethality of brain edema after a malignant middle cerebral artery infarction is ≤80%, and the only therapeutic intervention today is surgical removal of cranial bone to give brain room for swelling. 2 
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Alterations and disruption of the blood-brain barrier (BBB) play a key role in the development of cerebral edema. Anatomically, the BBB is a part of a NVU. NVU is composed of neurons, astrocytes, endothelial cells (ECs), pericytes, and the tight junctions (TJs) between the ECs. Change to any of these components leads to disruption of the BBB. 3 Little is known about the role of pericytes in the BBB. Recent studies have shown that pericytes migrate away from ECs after hypoxia. 4 In vitro experiments show that pericytes stabilize capillary-like structures. 5 A recent study has also suggested that pericyte constriction may be the cause of the long-lasting decrease of cerebral blood flow, thus damaging the BBB. 6 Pericytes have also been shown to be involved in angiogenesis and EC TJ formation, which is another important constituent of the BBB. 7 The TJ consists of 3 integral membrane proteins: claudin, occludin, and junction adhesion molecules. Decreased expression of TJ proteins (TJPs) is associated with BBB leakage after a focal cerebral ischemia. 8 Although survival from cerebral ischemia has improved over years, treatments affecting cerebral edema and BBB repair and regeneration are still lacking. Ischemia is one of the strongest stimuli for gene induction in the brain; it activates genes involved in a process of repair, remodeling, and angiogenesis. stages and are known as guidance molecules. 10 EphrinB2 and its receptor EphB4 belong to the most important guidance molecules shown to participate both in vascular remodeling and are involved in different components of the NVU formation. The Eph receptors comprise large families of tyrosine kinases receptors with 14 mammalian Ephs subdivided into EphA and EphB. Their ligands ephrin also fall into 2 subclasses; EphrinAs tethered to the membrane via glycosylphosphatidylinositol linkage and EphrinBs that are transmembrane glycoproteins. In general, EphAs (EphA1-8) preferentially bind to EphrinAs (ephrins A1-5) and EphBs (EphB1-6) to EphrinBs (ephrinB1-3). 11, 12 During development, the Eph-ephrin signaling system plays a diverse role in tissue patterning, cell migration, and axon guidance. 13, 14 Recently, genetic experiments in mice have shown that ephrinB2 is a critical regulator of vessel survival and pruning in the vasculature of the eye. 15 Most recently, ephrinB has been shown to play a crucial role in pericytes-to-endothelial assembly. Foo et al 16 have demonstrated that the expression of ephrinB2 in pericytes and mural cells is critical for the assembly of the vessel wall. This feature contributes to blood vessel maturation and stability, which is essential for the intact and functional NVU. Furthermore, different Eph-ephrin molecules have shown to be activated after stroke: EphA2 activation after stroke contributes to BBB damage and neuronal cell death, whereas astrocytic ephrinA5 inhibits axonal sprouting, and ephrinB3 deficiency enhances poststroke neurogenesis. [17] [18] [19] In contrast, the role of ephrinB2/EphB4 signaling in ischemic stroke is still unexplored.
In this study, we were able to show that an exogenous pharmacological agent can stimulate neurovascular ephrinB2/ EphB4 signaling after stroke, thereby enhancing vascular repair mechanism and reducing cerebral brain swelling. Furthermore, our retroviral modulation of ephrinB2/EphB4 signaling after stroke provides a proof of concept that ephrinB2/EphB4 signaling is important in the maintenance of neurovascular homeostasis, neurovascular protection, and in enhancing vascular repair mechanism. Thus, we present a novel therapeutic approach to reduce brain swelling after stroke.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Stroke and Damage to the NVU
We have used a 30-minute middle cerebral artery occlusion (MCAo) and reperfusion model in C57BL/6 mice, which leads to focal, ischemic cell death in striatum but not in the cortex ( Figure 1A ). Ischemic stroke and damage to the different cell types of the NVU was determined by immunostainings at different post-MCAo reperfusion time points (24 hours, 72 hours, 7 days, 14 days, and 28 days). Double staining for TUNEL and cell-type-specific markers was performed to examine the ischemic damage caused to different cell populations. Mature neuron-specific marker NeuN costained with TUNEL marked the neuronal cell loss in the ischemic lesion core on 7 days post-MCAo ( Figure Damage to the different cellular components of the NVU was accompanied by the loss of neurovascular integrity and disruption of the BBB, resulting in the development of brain swelling which peaked 24 hours after reperfusion, as demonstrated by T2-weighted magnetic resonance imaging ( Figure  IC in the online-only Data Supplement). A temporary lethargy of the animals and 10% loss of body weight was also observed ( Figure ID in the online-only Data Supplement). To further examine the neurovascular integrity, we injected Evans Blue dye, which vastly extravasated at 24 hours after reperfusion, confirming the post-MCAo disruption of BBB and loss of neurovascular integrity ( Figure 1C ). Multifluorescence immunostainings for TJPs in the areas of mild ischemiainduced neurovascular damage revealed decreased surface expression of claudin-5 and occludin at 24 hours post-MCAo ( Figure 1C ). As control, TJPs were unaltered, and no extravasation of Evans Blue was observed in the contralateral hemisphere ( Figure 1C ).
Vascular Recovery and Restoration of BBB
The longitudinal analysis of Evans Blue data demonstrated a stepwise reduction of Evans Blue extravasation, which was accompanied by increased surface expression of TJPs on blood vessels ( Figure 1C ). Thus, we sought to better understand this course of BBB recovery and neurovascular repair after MCAo. Brains examined 24 hours to 28 days post-MCAo showed increased cell proliferation in the ipsilateral striatal region. Cell proliferation significantly increased (P<0.001) after 72 hours post-MCAo with a few cells continuing to proliferate ≤28 days ( Figure IIA in the online-only Data Supplement). Then, we aimed to identify the proliferating cell types. Both vascular and perivascular cells showed proliferation after mild ischemia. Double labeling of CD31 and Ki67 showed EC proliferation in perilesion and lesion regions after 72 hours, 7 days ( Figure IIB in the online-only Data Supplement), 14 days, and on 28 days post-MCAo. This continued EC proliferation hallmarked the process of post-MCAo angiogenesis, which turned the perilesion and lesion core vascular system into a highly plastic vascular system with multiple angiogenic sprouts ( Figure  IIIA and IIIB in the online-only Data Supplement). EC proliferation and the formation of angiogenic sprouts finally resulted in a significantly increased blood vessel density, both in the perilesion and lesion region from 72 hours and 7 days onwards, respectively. Remarkably, the density of this new vascular system exceeded the density of the contralateral, unaffected hemisphere ( Figure IIIC in Data Supplement). From day 14 post-MCAo, the blood vessel density both in lesion and perilesion regions stabilized. Lectin perfusion on days 7 and 14 showed that the newly formed vessels were perfused, and thus functional in terms of providing nutritive blood supply ( Figure IV in the onlineonly Data Supplement). Next, we sought to understand the involvement of perivascular supporting cells in the course of BBB postischemic recovery. Desmin staining revealed that pericytic drop-off contributed to a loss of blood vessel integrity and increased vascular permeability within 24 hours post-MCAo (shown in Figure 1D ). However, from 72 hours on, double staining of desmin with KI67 showed pericyte proliferation both in lesion and perilesion regions ( Figure VA in the online-only Data Supplement). NG2 another pericyte marker also confirmed the pericyte proliferation ( Figure VB in the online-only Data Supplement). The repopulation of the endothelial lining with pericytes led to enhance endothelial-pericyte interactions and thus stabilization of the newly formed vessels (shown in Figure 1D ).
Overall, these results suggested that different mechanisms are initiated after mild brain ischemia to restore neurovascular homeostasis and to repair the NVU. Next, we aimed to examine, which molecules are involved in this repair mechanism.
EphrinB2/EphB4 Expression Time Course Profile After Ischemia
We focused our study on the relevance of neurovascular guidance molecules, which generally orchestrate the parallel development of the nervous and vascular system during embryological development. As part of a candidate screen, we investigated the mRNA expression of different guidance molecules at different time points after brain ischemia. EphrinB2 and EphB4 showed an early mRNA upregulation after ischemia which gradually normalized at 7 and 28 days post-MCAo, respectively (Figure 2A and 2B). Because the increased mRNA expression of ephrinB2 and EphB4 paralleled the BBB recovery, we focused our further studies on the role of ephrinB2/EphB4 in vascular repair after ischemia. Distribution and expression patterns revealed that EC and perivascular cells express ephrinB2 and EphB4 in the adult brain only at low levels under physiological conditions ( Figure 2C and 2D, left). However, after mild ischemia, both EC and perivascular cells expressed ephrinB2 and EphB4 at higher levels ( Figure 2C and 2D, right). In addition, we were able to show that reactive astrocytes highly express ephrinB2 and EphB4 after mild ischemia ( Figure 2C and 2D). Furthermore, costaining of CD31 with ephrinB2 marker showed ephrinB2 expression preferentially in angiogenic sprouts ( Figure VC in the online-only Data Supplement). Overall, we showed that the guidance molecules ephrinB2/EphB4 are activated in the adult brain after ischemia.
Overexpression of EphB4 Evokes Changes in Blood Vessel Morphology and Stabilizes BBB Via Recruiting Pericytes
To further examine their potential functional role in repair and recovery after mild ischemia, we manipulated the ephrinB2 signaling using a retroviral approach with the aim to achieve EphB4 overexpression that will result in an ephrinB2 activation phenotype, as previously shown by our group. 20 Therefore, an ecotropic retroviral vector (pLXSN) containing cDNA encoding full-length EphB4 (EphB4wt) was used to manipulate EphB4 expression.
The coordinates for the viral injection were determined using T2-weighted magnetic resonance images ( Figure VIA in the online-only Data Supplement). Forty-eight hours postMCAo, Phoenix E virus-producing cells were stereotactically injected into the ischemic hemisphere. The effect of infection with the virus containing the cDNA for EphB4wt was compared with the effects induced by the empty control vector (pLXSN) after 72 hours and 7 days post-MCAo. Before implantation, the Phoenix E cells were labeled with DiI to track the injected cell, which revealed that the cells were only localized at the site of implantation ( Figure VIB the normal post-MCAo recovery ( Figure 3B ). This included enhanced EC proliferation, which hallmarked vessel growth ( Figure 3C and 3E) .
EphB4 overexpression also resulted in a remarkable increase in pericyte proliferation ( Figure 3D and 3F) . The increased pericyte recruitment at the site of EphB4wt injection compared with the pLXSN injection resulted in an enhanced endothelial-pericyte interaction with more cerebral vessels being in contact with perivascular pericytes (Figure 4A and 4B). To further examine, if pericyte recruitment elicited an effect on vessel permeability and BBB characteristics, we injected Evans Blue dye and studied its extravasation kinetics. After EphB4 overexpression, Evans Blue extravasation was significantly reduced at 72 hours post-MCAo ( Figure These results emphasize the importance of ephrinB2/ EphB4 signaling in recovery after ischemic stroke. Activation of ephrinB2 accelerates vascular recovery via pericytes recruitment, enhances endothelial-pericyte interaction, and leads to a more rapid blood vessel sealing.
Local Knockdown of EphB4 Blocks EphrinB2-Mediated BBB Repair
We then analyzed whether siRNA-mediated knockdown of EphB4 (and thus inhibition of ephrinB2 signaling) would impair pericyte recruitment and restoration of the BBB. 
Pharmacological Stimulation of EphrinB2 Signaling
To study the therapeutic potential of ephrinB2/EphB4 signaling in repairing the BBB disturbances after ischemia, we stereotactically infused EphB4-Fc into the ischemic region 48 hours post-MCAo. The local infusion of EphB4-Fc enhanced the vascular recovery and BBB repair. Endothelial-pericyte association was dramatically improved from 72 hours onwards in the EphB4-Fc infused ischemic hemisphere compared with phosphate-buffered saline infusion ( Figure 6A and 6C) . Concurrently, Evans Blue extravasation was vastly decreased already at 72 hours post-MCAo ( Figure 6B Figure 6D ; Figure IXA in the online-only Data Supplement).
Multifluorescent immunostaining for the TJP occludin further revealed increased expression of these blood vessel sealing molecules ( Figure IXB in the online-only Data Supplement). These data are in line with the Phoenix E EphB4wt cell implantation data, indicating that activation of ephrinB2 signaling results in pericyte recruitment after mild ischemia and stabilization of the BBB.
EphrinB Phosphorylation During Vascular Remodeling and BBB Repair
Postnatal angiogenesis has been associated with ephrinB phosphorylation. Next, we aimed at investigating the status of ephrinB phosphorylation during the vascular repair phase after ischemia using a Phospho-EphrinB-specific antibody. The overexpression of EphB4 via phoenix cells led to increased ephrinB phosphorylation 72 hours post-MCAo, when compared with the pLXSN implantation. The increase of ephrinB phosphorylation was mainly detected in the vicinity of blood vessel, suggesting that ephrinB phosphorylation is mainly of perivascular nature ( Figure . This is in line with our data showing the poor BBB recovery after the siRNA-mediated knockdown of EphB4. Taken together, our data suggest that ephrinB phosphorylation mediates post-MCAo BBB repair.
EphrinB2 Activation Leads to Reduced Damage in Brain Tissue
To determine the influence of ephrinB2 activation on apoptosis, analysis of apoptotic cells was performed by using TUNEL staining. Total amount of TUNEL-positive cells were counted in the ipsilateral region. Our data demonstrate that the activation of ephrinB2 via EphB4 overexpression leads to reduced numbers of apoptotic cells when compared with pLXSN group. Whereas the knockdown of EphB4 significantly increases the number of cells undergoing apoptosis on day 7 post-MCAo ( Figure 7A , left and Figure 7B ). In addition, the number of detectable neurons in the ipsilateral hemisphere was significantly decreased in the knockdown group, whereas the number of neurons is high in the EphB4 overexpression group ( Figure 7A , right and Figure 7C ). These data suggest a neuroprotective role of the ephrinB2/EphB4 signaling.
Furthermore, the critical role of inflammation after brain ischemia and the contribution of ephrin/Eph signaling in regulating the process of inflammation and inflammatory cells infiltration have been previously discussed. 21, 22 Our data suggest that the inhibition of ephrinB2/EphB4 does not enhance inflammation after ischemia ( Figure XI in the online-only Data Supplement).
EphB4 Overexpression Involves Angiopoietin-1/ Tie2 System at the Endothelium/Pericyte Interface
As the involvement of angiopoietin-1 (Ang-1)/Tie2 in reducing vascular leakiness has been suggested, 20, 23 we investigated a link between ephrinB2 activation via EphB4 and Ang-1/ Tie2 system. The activation of ephrinB2 via EphB4 leads to an increase in Ang-1 expression in EphB4wt group compared with control group (pLXSN) and siRNA-EphB4 group ( Figure 8A ). This increased Ang-1 expression in EphB4wt group is mainly observed in PCs ( Figure 8B ). In addition, EphB4 overexpression also activates receptor Tie2 on endothelium. In EphB4wt group receptor, Tie2 was expressed at a higher level by the ECs (Figure 8C ). On the other hand, expression of ligand Ang-2 was also detected in all groups (EphB4wt, pLXSN, and siRNA-EphB4); however, in siRNA-EphB4 group, where ephrinB2/EphB4 signaling was inhibited, Ang-2 was expressed at a higher level ( Figure 8D ). Taken together, EphrinB2 activation via EphB4 seems to activate Ang-1/Tie2 system, which promotes blood vessel maturation and exerts a vessel sealing effect. Increased Ang-2 in siRNA-EphB4 suggests its involvement in BBB breakdown in the absence of EphB4.
Discussion
Stroke triggers a series of events that lead to a drastic loss of different cell types in the affected brain region. Within 24 hours, all principal neurovascular components undergo an orchestrated ischemic-induced damage. The early pericytic drop-off hallmarks the highly permeable vascular system resulting in the development of brain swelling. However, to some extent, brain also demonstrates the ability to recover from brain ischemia. It endeavors to compensate for the cellular loss by increasing cell proliferation and migration of proliferating cells to the damaged brain region. [24] [25] [26] Proliferation and migration of ECs has been shown to be an essential criterion for angiogenesis. [27] [28] [29] We demonstrate active EC proliferation that turns the ischemic hemisphere into a highly plastic vascular system with multiple angiogenic sprouts. The continued angiogenic sprouting results in an increased vessel density in both perilesion and lesion region. The increase in vessel density after MCAo correlates with longer survival in patients. 30 Both angiogenesis and EC turnover stay constant from 14 days post-MCAo, suggesting that during the first 2 weeks cell recruitment, migration and vascular sprouting occurs, whereas later on the newly formed vascular system stabilizes. These observations suggest that, in response to brain ischemia, an intrinsic mechanism reorganizes and repairs the damaged vascular system in the lesion and perilesion areas.
Altogether, our current knowledge of post-MCAo recovery suggests an important role of angiogenesis in vascular remodeling and thus improving collateral circulation. 31 However, angiogenesis alone would have less impact on repair, if the BBB is not restabilized. In this study, we present insights into the integral role of pericytes in the normal course of endogenous BBB recovery after cerebral ischemia. Recent studies have shown the importance of pericytes in stabilizing and maintaining the BBB. [32] [33] [34] Pericytes have also been shown to migrate away from blood vessels in response to traumatic brain injury. 35 Gonul et al 4 demonstrated that pericytes of the BBB are the first cells to respond to brain hypoxia in cats. In agreement with this, we show 40% pericyte-negative vessels in the infarct core region 24 hours after MCAo. The pericyte drop-off has a drastic impact on the vascular permeability and in part is responsible for post-MCAo brain swelling. In the context of a repair of this vascular damage, our data demonstrate enhanced pericyte recruitment to the blood vessel wall within 72 hours, which is accompanied by reduced extravasation of Evans Blue. In summary, pericyte recruitment to the nascent blood vessels is pivotal in stabilization and repair of the cerebral vascular system after mild ischemia.
Our data are in agreement with the current state of knowledge that post-MCAo recovery involves vascular remodeling and BBB repair. However, the molecular players behind this functional recovery had not yet been identified. Here, we identify the guidance molecule ephrinB2 as a key player in vascular normalization and vascular growth after MCAo. The importance of ephrinB2/EphB4 signaling was shown to be pivotal in prenatal and tumor angiogenesis. 36, 37 In tumor, the cell-cell interaction between EphB4 and ephrinB2 promotes angiogenesis and vascular remodeling. Noren et al 38 have demonstrated that tumoral EphB4 promotes tumor guidance Figure 3A . Costaining of Ki67-desmin showed reduced proliferating pericytic cells (A). Endothelial-pericyte interaction was decreased, resulting in blood vessels lacking pericyte coverage on d 7 post-MCAo (B). Focal knockdown of EphB4 leads to a significant decrease in the percentage of desmin-positive vessels (C). Quantification of the extravasation area and immunofluorescence staining reveals a significantly increased cerebrovascular permeability and delay of vascular repair in EphB4-siRNA versus control animals (D and E). n=8 (***P<0.001, *P<0.05) values are represented as ±SEM, and 2-tailed Student t test is conducted. Magnification ×200; scale bar, 50 μm.
by stimulating angiogenesis through ephrinB2. Hayashi et al 39 show increased expression of ephrinB2 and EphB4 already 1 hour post-MCAo. We found ephrinB2 to be upregulated even at 72 hour post-MCAo, and the expression of its tyrosine kinase receptor EphB4 continues to be elevated ≤14 days post-MCAo. We demonstrated upregulation of these guidance molecules in endothelial and perivascular support cells. Angiogenesis involves the proliferation of ECs, and the recruitment of perivascular cells ensures that the newly formed blood vessels are stable and nonleaky. Therefore, post-MCAo upregulation of ephrinB2/EphB4 in these cell types provides further evidence of their active participation in repair and remodeling. Furthermore, it is well know that ephrinB2/EphB4 possess a unique bidirectional signaling system. 40 EphrinB2 can also function as a receptor, depending in part on tyrosine phosphorylation of the ephrinB2 cytoplasmic domain mediated by the Src family kinase (reverse signaling). 41 Activation of ephrinB2 reverse signaling by EphB4 has been shown to be proangiogenic 42 and to induce cell attachment and migration. 43 These observations led us to hypothesize that local overexpression of EphB4 should activate ephrinB2 and may accelerate vascular recovery via pericyte recruitment and tightening of endothelium-pericyte interactions. Indeed, we demonstrated that the activation of ephrinB2 via EphB4 overexpression significantly increased EC and perivascular cell proliferation. EphrinB2 activation via EphB4wt led to an enhanced endothelial-pericyte interaction compared with our pLXSN implantation, resulting in a markedly reduced vascular permeability. In parallel, TJPs, such as claudin-5 and occludin, were markedly increased from 72 hours after MCAo. These results suggest that pericytes not just stabilize the blood vessels but also rehabilitate the TJs by increasing the expression of TJPs, hereby leading to the early BBB repair after mild ischemia. Furthermore, the activation of ephrinB2 was accompanied by accelerated clinical recovery of the animals, thus providing evidence that early BBB repair leads to faster recovery from ischemia and modulating that ephrinB2/EphB4 system can accelerate this recovery process. On the contrary, blocking the ephrinB2 activation via siRNA-mediated knockdown of EphB4 resulted in an aggravation of brain swelling. As the involvement of Ang-1/Tie2 system in reducing tumor blood vessel permeability after ephrinB2 activation has been previously shown. 20 We aimed to study their role after ischemia. Angiopoietins/Tie2 also play an important role in development and stability of the blood vessels, 44, 45 and it has been shown that their expression is altered during BBB breakdown. 46 Here, we show that ephrinB2 activation leads to an increased expression of Ang-1 mainly in PCs after ischemia. Parallel to this, expression of receptor Tie2 is also enhanced in the ECs. The upregulation of Ang-1/Tie2 and rapid stabilization of vasculature in EphB4 overexpressing animals after MCAo suggests a link between ephrinB2/EphB4 signaling. On the contrary, siRNA-mediated knockdown of EphB4 results in decreased Ang-1/tie 2 expression, however, enhanced Ang-2 expression. Ang-2 is known to block the stabilization function of Ang-1 leading to loosening of endothelial/pericyte interaction. This might explain the increased vascular permeability in siRNA-EphB4 group. It further suggests that the blockage of ephrinB2/EphB4 signaling inactivates the Ang-1/Tie2 axis between EC and PCs and results in a unstable, leaky vascular system. Taken together, our study suggests that ephrinB2/ephB4 signaling regulates angiopoietins/Tie2 system under ischemic condition.
Next, we explored the possibility of using ephrinB2/ EphB4 signaling system as a therapeutic target by applying EphB4-Fc fragments. EphB4-Fc has been shown to activate ephrinB2 and being involved in angiogenesis. 42 Furthermore, it has been shown that the treatment of human retinal cells with EphB4-Fc results in activating Scr pathway (ephrinB2 reverse signaling). 47 In our experiments, local infusion of EphB4-Fc had a similar effect as the overexpression of EphB4 by the Phoenix E cells. Comparing our results to other Eph receptor such as EphA2, our data show that overexpressing EphB4 improves vascular permeability after ischemia. EphA2 promotes permeability after lung injury [48] [49] [50] and has an inhibitory effect on angiogenesis in brain ECs. 51 Furthermore, EphA2 directly contributes to BBB damage after ischemic stroke. 17 Our data suggest that increase in EphB4 expression accelerates neurovascular repair after mild cerebral ischemia. Thus, EphB4 might be better in BBB restoration than EphA2. In short, activating ephrinB2/EphB4 signaling via pharmacological means is a novel therapeutic approach to reduce brain swelling after cerebral ischemia.
Our study is an exploratory (discovery) study design conducted according to the initial Stroke Therapy Academic Industry Roundtable recommendations, where the initial studies are recommended in young, healthy animals. 52 Using 12 to 14 weeks animals, we analyze the reorganization of the neurovascular network in the adult brain after ischemic stroke and the role played by ephrinB2/EphB4 signaling in mediating the poststroke repair. Further studies using aged animals should be conducted as a part of confirmatory study.
One limitation of our study is that we are not able to clarify the contribution of endothelial-endothelial and endothelial-pericyte dysfunction on BBB function when targeting ephrinB2/EphB4. The focus of our study was to analyze the role of ephrinB2/EphB4 in vascular repair and in BBB restoration after mild cerebral ischemia. Our data provide mechanistic insights into how ephrinB2/EphB4 act at the BBB; however, with our experimental approach, we cannot definitely conclude which cell-cell interaction mainly influences the BBB regulation. The ephrinB2/EphB4 effects observed at the BBB might be because of the intercellular communication between EC and PC. However, endothelial-endothelial interaction might also be involved in BBB regulation. BBB is a part of NVU, which is composed of neurons, astrocytes, ECs, pericytes, and TJs between the ECs. Because of this complex composition, both BBB and NVU cannot be broken down to EC-EC contacts. As also shown in our expression pattern of ephrinB2/EphB4 on all cells involved in forming, the BBB and NVU make clear that intercellular communication within this microenvironment cannot be reduced to the level of the endothelial lining ( Figure 2C and 2D) . Our data point out that ephrinB2/EphB4 are upregulated in both ECs and pericytes after MCAo and also improved our understanding of the role of EC and pericyte dysfunction in BBB. However, for the translation of the mechanism into clinical relevance, it is crucial to conduct further studies in decoding the role of ephrinB2/EphB4 signaling at BBB interface after mild ischemia.
In summary, our findings suggest that the guidance molecule ephrinB2 plays a key role in vascular repair and remodeling after ischemia and may offer an attractive target for novel approaches, which aim at accelerating vascular repair after MCAo and reducing post-MCAo brain swelling. Therapeutic activation of ephrinB2 reverse signaling will enhance EC and PC proliferation, tighten endothelial-pericyte interaction, and repair the BBB. 
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